Cite

HARVARD Citation

    Racil, Z. et al. (n.d.). Insulin resistance is an underlying mechanism of impaired glucose metabolism during nilotinib therapy. American journal of hematology. 93 (10), pp. E342-E345. [Online]. 
  
Back to record